Skip to main content
Skip to content
Case File
efta-efta00668285DOJ Data Set 9Other

From: Steven Victor MD ‹

Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00668285
Pages
1
Persons
0
Integrity

Summary

Ask AI About This Document

0Share
PostReddit

Extracted Text (OCR)

EFTA Disclosure
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Steven Victor MD ‹ > To: Subject: Great news re Patent Date: Fri, 18 Jan 2013 16:17:05 +0000 Dear Shareholder, Investor and Friend, We have received a notice of allowance from the US Patent Office for our U.S. Patent Application No. 13/323,030 for the Invention "Ultrasonic Cavitation Derived Stromal Vascular Fraction and Cells Derived therefrom obtained from Adipose Tissue and Use Thereof. The patent application contains claims drawn to a method of using ultrasonic cavitation to isolate stromal vascular fraction cells from adipose tissue without requiring the use of enzymes. This mean the patent is allowed and will be for final publication in approx 30 days after we pay the application fee. I believe this is a major step forward for the company and I thank the entire staff for their hard work. We look forward to an exciting and fruitful 2013. Steven Victor MD IntelliCell BioSciences Chairman/CEO 460 Park Avenue 17th Floor New York, New York 10022 212-249-3050 Fax 212-249-1482 Cell 917-459-8252 www.IntelliCellBioSciences.com EFTA00668285

Technical Artifacts (5)

View in Artifacts Browser

Email addresses, URLs, phone numbers, and other technical indicators extracted from this document.

Domainwww.intellicellbiosciences.com
FaxFax 212-249-1482
Phone212-249-1482
Phone212-249-3050
Phone917-459-8252

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.

Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.